Cross-study safety analysis of risk factors in CAR T cell clinical trials: An FDA database pilot project
2022 · Molecular Therapy — Oncolytics · 4 citations
https://doi.org/10.1016/j.omto.2022.10.006
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
62
Papers
5.8K
Citations
36
h-index
44
i10-index
Wilson W. Bryan is an academic researcher. The author has contributed to research in topics: Amyotrophic Lateral Sclerosis Research & Neurogenetic and Muscular Disorders Research & CAR-T cell therapy research. The author has an h-index of 36, co-authored 53 publications.
Click to start Chat